Eric Langer has over 25 years experience in biotechnology and life sciences strategic marketing management, market research, and publishing. He has held senior management and marketing positions at biopharmaceutical supply companies. He has published and authored many books and reports on topics in Biotechnology, Large-scale BioManufacturing, and bioscience commercialization and communication. He teaches at Johns Hopkins University marketing management, biotech marketing, services marketing, and marketing in a regulated environment. In 1989 he co-founded BioPlan Associates, Inc. to provide market analysis, and strategy to biotech and healthcare organizations.

Fill/finish operations continue to be dominated by trends in automation and the adoption of single-use equipment. But these are by no means the only factors affecting these high-value operations.

Outsourcing

Manufacturing

Manufacturing, Fill/Finish

Contract Packaging, Logistics, and Distribution

Manufacturing, Biologics

Contract Manufacturing, Sterile, Aseptic Processing

Contract Manufacturing, Finished Drug Product

BioPharm International-06-15-2015

BioPharm International

Automation and disposables continue to reduce human error.

Fill/Finish Trends